GlassScriptPhysician profile
Omar Hussain
NPI 1083349278
$823.72
in general payments reported to CMS, 2019-2025
11 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $164 · 2024: $248 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $286.22 | 2023-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Acumed LLC | $205.81 | 2023-2025 | Osteomed, Acumed, Acumed |
| Next Science LLC | $137.02 | 2023-2025 | Xperience, Blastx, Surgx |
| Averitas Pharma INC. | $53.06 | 2024-2025 | Qutenza |
| Davol INC. | $30.13 | 2025 | Arista |
| Tactile Systems Technology INC | $25.53 | 2025 | Nimbl, Flexitouch Plus |
| Abbvie INC. | $18.91 | 2024 | |
| Advanced Oxygen Therapy INC. | $18.29 | 2025 | Topical Oxygen Chamber For Extremities |
| Convatec INC. | $16.69 | 2025 | |
| Solventum Corporation | $16.69 | 2024 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Vertex Pharmaceuticals Incorporated | $15.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.